Retroperitoneal Sarcoma Clinical Trial
Official title:
Randomized Controlled Trial of Repeat vs. Single Quadratus Lumborum Block to Reduce Opioid Prescriptions After Open Resection of Retroperitoneal Sarcoma ("RESQU-SARC" Trial)
This phase II trial studies how well a repeat or single liposomal bupivacaine injection (quadratus lumborum block) works in reducing opioid prescriptions after surgery in patients with retroperitoneal sarcoma. Liposomal bupivacaine is a numbing medication. Giving a second injection block may decrease dependency on opioid medications for pain relief after surgery and prevent long-term use and addiction.
PRIMARY OBJECTIVE: I. To use a pragmatic phase II randomized controlled trial to compare two standardized bundles of usual care for postoperative pain management to reduce the initial discharge prescription opioid volume. SECONDARY OBJECTIVE: I. To assess which pragmatic arm improves aspects of postoperative recovery including 30-day, 3-month, and 1-year opioid use, patient symptom inventory at those time points, hospital measures including length of stay and inpatient pain scores. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive standard of care liposomal bupivacaine injection before and during surgery and standard of care non-opioids and opioids at days 0-3 after surgery in the absence of unacceptable toxicity. ARM II: Patients receive standard of care liposomal bupivacaine injection before and during surgery and standard of care non-opioids and opioids at days 0-3 after surgery in the absence of unacceptable toxicity. Patients then receive a second liposomal bupivacaine injection on day 4 after surgery. After completion of study treatment, patients are followed up at 1, 3, and 12 months after the surgery. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03838718 -
REtroperitoneal SArcoma Registry: an International Prospective Initiative
|
||
| Enrolling by invitation |
NCT05844813 -
Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
|
Phase 4 | |
| Terminated |
NCT00901836 -
Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma
|
N/A | |
| Completed |
NCT05044624 -
Retroperıtoneal Soft-Tıssue Sarcomas
|
N/A | |
| Completed |
NCT04225494 -
Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas
|
||
| Active, not recruiting |
NCT03792867 -
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
|
N/A | |
| Not yet recruiting |
NCT06025747 -
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
|
Phase 1 | |
| Active, not recruiting |
NCT04224948 -
The PET- Retroperitoneal Sarcoma Study
|
N/A | |
| Recruiting |
NCT04031677 -
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
|
Phase 3 | |
| Recruiting |
NCT05224934 -
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma
|
Phase 2 | |
| Completed |
NCT03877588 -
Nutritional Status in Retroperitoneal Sarcoma.
|
N/A | |
| Completed |
NCT02384473 -
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
|
Early Phase 1 | |
| Withdrawn |
NCT05302570 -
Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS
|
Phase 2 | |
| Recruiting |
NCT01659203 -
Proton or Photon RT for Retroperitoneal Sarcomas
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05631379 -
Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma
|
||
| Recruiting |
NCT06327477 -
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
|
Phase 1/Phase 2 |